全文获取类型
收费全文 | 105758篇 |
免费 | 8236篇 |
国内免费 | 3547篇 |
专业分类
耳鼻咽喉 | 1850篇 |
儿科学 | 5013篇 |
妇产科学 | 635篇 |
基础医学 | 11257篇 |
口腔科学 | 1094篇 |
临床医学 | 10988篇 |
内科学 | 24194篇 |
皮肤病学 | 609篇 |
神经病学 | 6888篇 |
特种医学 | 2923篇 |
外国民族医学 | 6篇 |
外科学 | 24638篇 |
综合类 | 12631篇 |
现状与发展 | 15篇 |
一般理论 | 3篇 |
预防医学 | 3510篇 |
眼科学 | 1820篇 |
药学 | 5331篇 |
27篇 | |
中国医学 | 1586篇 |
肿瘤学 | 2523篇 |
出版年
2024年 | 142篇 |
2023年 | 1523篇 |
2022年 | 2354篇 |
2021年 | 3879篇 |
2020年 | 3834篇 |
2019年 | 4020篇 |
2018年 | 4087篇 |
2017年 | 3627篇 |
2016年 | 3510篇 |
2015年 | 3516篇 |
2014年 | 6638篇 |
2013年 | 6901篇 |
2012年 | 5344篇 |
2011年 | 6411篇 |
2010年 | 5597篇 |
2009年 | 5727篇 |
2008年 | 5925篇 |
2007年 | 5682篇 |
2006年 | 5478篇 |
2005年 | 4762篇 |
2004年 | 3851篇 |
2003年 | 3273篇 |
2002年 | 2650篇 |
2001年 | 2290篇 |
2000年 | 2019篇 |
1999年 | 1599篇 |
1998年 | 1402篇 |
1997年 | 1231篇 |
1996年 | 1052篇 |
1995年 | 970篇 |
1994年 | 954篇 |
1993年 | 665篇 |
1992年 | 796篇 |
1991年 | 570篇 |
1990年 | 419篇 |
1989年 | 410篇 |
1988年 | 447篇 |
1987年 | 332篇 |
1986年 | 287篇 |
1985年 | 404篇 |
1984年 | 372篇 |
1983年 | 278篇 |
1982年 | 310篇 |
1981年 | 290篇 |
1980年 | 294篇 |
1979年 | 224篇 |
1978年 | 208篇 |
1977年 | 185篇 |
1976年 | 163篇 |
1975年 | 149篇 |
排序方式: 共有10000条查询结果,搜索用时 46 毫秒
1.
《European journal of surgical oncology》2022,48(3):621-631
ObjectivesThe aim of this meta-analysis was to conduct a contemporary systematic review of high quality non-randomised controlled trials to determine the effect of pre-liver transplantation (LT) transarterial chemoembolisation (TACE) on long-term survival and complications of hepatocellular carcinoma (HCC) patients.BackgroundTACE is used as a neoadjuvant therapy to mitigate waitlist drop-out for patients with HCC awaiting LT. Previous studies have conflicting conclusions on the effect of TACE on long-term survival and complications of HCC patients undergoing LT.MethodsCINAHL, Cochrane Controlled Register of Trials, Embase, PubMed, and Web of Science were systematically searched. Baseline characteristics included number of patients outside Milan criteria, tumour diameter, MELD score, and time on the waiting list. Primary outcomes included 3- and 5-year overall and disease-free survival. Secondary outcomes included tumour recurrence, 30-day postoperative mortality, and hepatic artery and biliary complications.ResultsTwenty-one high-quality NRCTs representing 8242 patients were included. Tumour diameter was significantly larger in TACE patients (3.49 cm vs 3.15 cm, P = 0.02) and time on the waiting list was significantly longer in TACE patients (4.87 months vs 3.46 months, P = 0.05), while MELD score was significantly higher in non-TACE patients (10.81 vs 12.35, P = 0.005). All primary and secondary outcomes displayed non-significant differences.ConclusionPatients treated with TACE had similar survival and postoperative outcomes to non-TACE patients, however, they had worse prognostic features compared to non-TACE patients. These findings strongly support the current US and European clinical practice guidelines that neoadjuvant TACE can be used for patients with longer expected waiting list times (specifically >6 months). Randomised controlled trials would be needed to increase the quality of evidence. 相似文献
2.
3.
4.
《Transfusion and apheresis science》2022,61(1):103368
The endothelium is a single-layered structure that responds to physical and chemical signals with various factors it synthesizes. In the early days of its discovery, as the inner wall of the vessels, the endothelium was thought to be a simple barrier that lays on the surface. Over time it is discovered that endothelium maintains body homeostasis with the molecules it synthesizes, despite its simple single-layer structure. It has been accepted as an important organ that contributes to the maintenance of vascular tone, cell adhesion, inflammation, vascular permeability and coagulation. Any imbalance in these physiological and pathological events causes endothelial dysfunction. This can cause many diseases such as atherosclerosis, hypertension, diabetes, or it can occur because of these. Endothelial related disorders may also complicate hematopoietic stem cell transplantation (HSCT), which is used to treat various hematologic and neoplastic diseases. These life-threatening complications include graft-versus-host disease, hepatic veno-occlussive disease, transplant-associated thrombotic microangiopathy and diffuse alveolar hemorrhage. They share a similar pathophysiology involving endothelial cells with different clinical presentations. Therefore, current researche on the issue is putting the endothelium under the spotlight for novel markers and treatment options that should be used to monitor or treat at least some of these complications following HSCT. 相似文献
5.
6.
7.
8.
《Journal of Radiology Nursing》2022,41(3):166-169
PurposeIn 2018, The Journal of Vascular and Interventional Radiology (JVIR) updated its guidelines regarding periprocedural antibiotics. However, some institutions are slower to adopt these new guidelines. Additionally, antibiotic-resistant bacteria and sepsis are serious concerns due in part to incorrect usage of antibiotics. The purpose of this study is to assess institutional adherence to 2018 JVIR guidelines for the purpose of improving antibiotic stewardship.Materials and methodsA total of 800 cases over a 10-month time period were retrospectively identified and charted following the release of guidelines. Inclusion criteria for the study were adults aged 21 years or older undergoing mediport placement, tunneled central line (TCL) placement, nephrostomy tube exchange, percutaneous biliary drain, or cholecystostomy tube exchange. Exclusion criteria included immunocompromised and pregnant individuals as 2018 guidelines may not fit these patient populations. Guideline adherence for each procedure was recorded as a percentage; the timing of the antibiotic usage was also recorded and compared to the guidelines (within 60 minutes before incision).ResultsIn total, 49 mediport placements, 118 tunneled central line placements – 44 hemodialysis (HD) catheters and 74 nonhemodialysis (non-HD) catheters, 100 nephrostomy exchanges, and 82 biliary tube exchanges were included. Antibiotics were used in 83.6% (41/49) of mediport patients, 11.3% (5/44) of non-HD TCL patients, 20.5% (15/74) of HD TCL patients, 55% (55/100) nephrostomy tube changes, and 65.4% (55/84) of biliary or cholecystostomy tube exchanges. Out of those given prophylaxis, guideline-recommended antibiotics were used in 100% (41/41) of mediport, 100% (20/20) of TCL (both HD and non-HD catheters), 9% (5/55) of nephrostomy tube exchanges, and 1.8% (1/55) of biliary tube exchanges. Guideline-recommended timing was followed in 75.3% across all cases (ranging from 72.2% in mediports to 79.3% in biliary exchanges).ConclusionThis study of antibiotic practices at a single university-based academic institution revealed that antibiotic usage is not fully up to date with 2018 guidelines. For mediports, non-HD TCL placements, and nephrostomy tube exchanges, institutional changes should be made to reduce periprocedural antibiotic use, as antibiotics are no longer recommended for these procedures. For HD TCL and biliary exchanges, proper adherence to recommended prophylactic antibiotics should be followed. In addition, education about the correct antibiotic timing should be emphasized to increase compliance with guidelines. 相似文献
9.
10.